• 1
    de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de VJ. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:12091220.MEDLINE
  • 2
    Del Prete G, De CM, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353360.MEDLINE
  • 3
    Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11:165190.MEDLINE
  • 4
    Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994; 56:126.MEDLINE
  • 5
    Peguet NJ, Moulon C, Caux C, Dalbiez GC, Banchereau J, Schmitt D. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans' cells. Eur J Immunol 1994; 24:884891.MEDLINE
  • 6
    Powrie F, Menon S, Coffman RL. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993; 23:30433049.MEDLINE
  • 7
    Duchmann R, Schmitt E, Knolle P, Meyer zum Büschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996; 26:934938.MEDLINE
  • 8
    Groux H, Bigler M, de VJ, Roncarolo MG. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996; 184:1929.MEDLINE
  • 9
    Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A, De Groote D, et al. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994; 24:11671171.MEDLINE
  • 10
    Lumsden A, Henderson J, Kutner M. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988; 8:232236.MEDLINE
  • 11
    Yasui M, Nakao A, Yuuki T, Harada A, Nonami T, Takagi H. Immunohistochemical detection of endotoxin in endotoxemic rats. Hepatogastroenterology 1995; 42:683690.MEDLINE
  • 12
    Shnyra A, Lindberg AA. Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro. Infect Immun 1995; 63:865873.MEDLINE
  • 13
    Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Büschenfelde KH, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. Hepatology 1995; 22:226229.
  • 14
    Knolle P, Protzer U, Uhrig A, Rose-John S, Meyer zum Büschenfelde KH, Gerken G. Differential regulation of endotoxin induced IL-6 production in sinusoidal endothelial cells and Kupffer cells. Clin Exp Immunol 1997; 107:555563.MEDLINE
  • 15
    Knolle PA, Löser E, Schmitt E, Meyer zum Büschenfelde KH, Gerken G, Lohse AW. T cell activation by antigen presenting liver sinusoidal endothelial cells: modulation by cytokines. Submitted.
  • 16
    Steffan AM, Gendrault JL, McCuskey RS, McCuskey PA, Kirn A. Phagocytosis, an unrecognized property of murine endothelial liver cells. Hepatology 1986; 6:830836.MEDLINE
  • 17
    Horikoshi T, Danenberg K, Stadlbauer T, Volkenandt M, Shea L, Aigner K, Gustavsson B, et al. Quantitation of thymidylate synthase, dihydrofolate reductase and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res 1992; 52:108116.MEDLINE
  • 18
    Ho AS, Liu Y, Khan TA, Hsu DH, Bazan JF, Moore KW. A receptor for interleukin 10 is related to interferon receptors. Proc Natl Acad Sci 1993; 90:1126711271.MEDLINE
  • 19
    Barsig J, Kusters S, Vogt K, Volk HD, Tiegs G, Wendel A. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha. Eur J Immunol 1995; 25:28882893.MEDLINE
  • 20
    Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grunig G, et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 1995; 96:23392347.MEDLINE
  • 21
    Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 1995; 155:22222229.MEDLINE
  • 22
    Gazzinelli R, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kühn R, Müller W, et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ and TNFα. J Immunol 1996; 157:798805.MEDLINE
  • 23
    Chisari FV. Hepatitis B virus transgenic mice: insights into the virus and the disease. Hepatology 1995; 22:13161326.MEDLINE
  • 24
    Mosnier JF, Pham BN, Walker F, Dubois S, Degos F, Erlinger S, Degott C. Relationship between composition of lymphoid cell infiltrates in the liver and replication status in chronic hepatitis B: an immunohistochemical study. Am J Clin Pathol 1996; 106:625633.MEDLINE
  • 25
    Hashimoti E, Kojimahara N, Noguchi S, Taniai M, Ishiguro N, Hayashi N. Immunohistochemical characterization of hepatic lymphocytes in acute hepatitis A, B, and C. J Clin Gastroenterol 1996; 23:199202.MEDLINE
  • 26
    Knolle P, Uhrig A, Gerken G. IL-10 mediated downregulation of accessory molecules on liver sinusoidal endothelial cells. (manuscript in preparation)
  • 27
    Weber NR, Meraz MA, Schreiber RD. Lipopolysaccharide-dependent induction of IL-10 receptor expression on murine fibroblasts. J Immunol 1994; 153:37343744.MEDLINE
  • 28
    Will A, Hemmann U, Horn F, Röllinghoff M, Gessner A. Intracellular murine IFN-γ mediates virus resistance, expression of oligoadenylate synthetase, and activation of STAT transcription factors. J Immunol 1996; 157:45764583.MEDLINE